Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp | EVP of R&D & CTO | Restricted Stock Units | 7.35K | $304K | $41.42 | Jan 29, 2025 | Direct |
QuidelOrtho Corp | EVP of R&D & CTO | Non-Qualified Stock Options | 7.35K | Jan 29, 2025 | Direct | ||
QuidelOrtho Corp | EVP of R&D & CTO | No securities beneficially owned | 0 | Oct 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QDEL | QuidelOrtho Corp | Jan 29, 2025 | 2 | $0 | 4 | Jan 31, 2025 | EVP of R&D & CTO |
QDEL | QuidelOrtho Corp | Oct 7, 2024 | 0 | $0 | 3 | Oct 17, 2024 | EVP of R&D & CTO |